Managing childhood asthma: Challenge of preventing exacerbations

Pediatrics

Volumn 123, Issue SUPPL. 3, 2009, Pages

  Martinez, Fernando D ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Acute disease; Childhood asthma; Control; Prevention

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE; FORMOTEROL; MONTELUKAST; NEDOCROMIL; PLACEBO; PREDNISONE; SALBUTAMOL; SALMETEROL;

ASTHMA; CHILD CARE; CHILDHOOD DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONSULTATION; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; HUMAN; MORBIDITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE;

ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ASTHMA; CHILD; CHILD, PRESCHOOL; DISEASE MANAGEMENT; DRUG THERAPY, COMBINATION; EOSINOPHILS; HUMANS; NEBULIZERS AND VAPORIZERS; NEUTROPHIL INFILTRATION; PICORNAVIRIDAE INFECTIONS; RHINOVIRUS; SPUTUM;

EID: 63449127873     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-2233D     Document Type: Review

References (28)

1. National Asthma Education and Prevention Program Coordinating Committee. Expert Panel Report 3 (EPR3): Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Heart, Lung, and Blood Institute; 2007. Available at: www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm. Accessed April 18, 2007
2. Schatz M, Mosen D, Apter AJ, et al. Relationships among quality of life, severity, and control measures in asthma: an evaluation using factor analysis. J Allergy Clin Immunol. 2005; 115(5):1049-1055
3. Bacharier LB, Phillips BR, Bloomberg GR, et al. Severe intermittent wheezing in preschool children: a distinct phenotype. J Allergy Clin Immunol. 2007;119(3):604-610
4. Bacharier LB, Strunk RC, Mauger D, White D, Lemanske RF Jr, Sorkness CA. Classifying asthma severity in children: mismatch between symptoms, medication use, and lung function. Am J Respir Crit Care Med. 2004;170(4):426-432
5. Hoskins G, McCowan C, Neville RG, Thomas GE, Smith B, Silverman S. Risk factors and costs associated with an asthma attack. Thorax. 2000;55(1):19-24
6. Juniper EF, GuyattGH, EpsteinRS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health-related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax. 1992;47(2):76-83
7. Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med. 2000;343(15):1054-1063
8. Bisgaard H, Zielen S, Garcia-Garcia ML, et al. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med. 2005;171(4): 315-322
9. Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med. 2006;354(19):1985-1997
10. Sorkness CA, Lemanske RF Jr, Mauger DT, et al. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. J Allergy Clin Immunol. 2007;119(1):64-72
11. Johnston SL, Pattemore PK, Sanderson G, et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med. 1996;154(3):654-660
12. Grünberg K, Timmers MC, de Klerk EP, Dick EC, Sterk PJ. Experimental rhinovirus 16 infection causes variable airway obstruction in subjects with atopic asthma. Am J Respir Crit Care Med. 1999;160(4):1375-1380
13. Murray CS, Poletti G, Kebadze T, et al. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax. 2006;61(5):376-382
14. Wark PA, Johnston SL, Bucchieri F, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med. 2005;201(6):937-947
15. Contoli M, Message SD, Laza-Stanca V, et al. Role of deficient type III iterferon-λ production in asthma exacerbations. Nat Med. 2006;12(9):1023-1026
16. Kotenko SV, Gallagher G, Baurin VV, et al. IFN-As mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol. 2003;4(1):69-77
17. Sheppard P, Kindsvogel W, Xu W, et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol. 2003;4(1): 63-68
18. Norzila MZ, Fakes K, Henry RL, Simpson J, Gibson PG. Inter- leukin-8 secretion and neutrophil recruitment accompanies induced sputum eosinophil activation in children with acute asthma. Am J Respir Crit Care Med. 2000;161(3):769-774
19. Simpson JL, Scott R, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology. 2006;11(1):54-61
20. Barnes PJ. New molecular targets for the treatment of neutro- philic diseases. J Allergy Clin Immunol. 2007;119(5):1055-1062
21. Jayaram L, Pizzichini MM, Cook RJ, et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J. 2006;27(3):483-494
22. Maneechotesuwan K, Essilfie-Quaye S, Kharitonov SA, Adcock IM, Barnes PJ. Loss of control of asthma following inhaled corticosteroid withdrawal is associated with increased sputum interleukin-8 and neutrophils. Chest. 2007;132(1): 98 -105
23. National Asthma Education and Prevention Program Coordinating Committee. Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health; 1997. Publication NIH 97-4051
24. O'Byrne PM, Bisgaard H, Godard PP, et al. Budesonide/ formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med. 2005; 171(2):129-136
25. Martinez FD. Safety of long-acting β-agonists: an urgent need to clear the air. N Engl J Med. 2005;353(25):2637-2639
26. Papi A, Canonica GW, Maestrelli P, et al. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med. 2007;356(20):2040-2052
27. Murray CS, Woodcock A, Langley SJ, Morris J, Custovic A. Secondary prevention of asthma by the use of inhaled fluticasone propionate in wheezy infants (IFWIN): double-blind, randomised, controlled study. Lancet. 2006;368(9537):754-762
28. Bisgaard H, Hermansen MN, Loland L, Halkjaer LB, Buchvald F. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med. 2006;354(19):1998-2005